Back to Journals » Vascular Health and Risk Management » Volume 8

The potential benefit of stem cell therapy after stroke: an update

Authors Banerjee S, Williamson, Habib N , Chataway

Received 11 May 2012

Accepted for publication 14 August 2012

Published 10 October 2012 Volume 2012:8 Pages 569—580


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Video abstract presented by Soma Banerjee

Views: 627

Soma Banerjee,1 Deborah A Williamson,2 Nagy Habib,3 Jeremy Chataway4,5

1Department of Stroke Medicine, Imperial College Healthcare NHS Trust, London, UK; 2Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand; 3Department of Surgery, Imperial College London, London, UK; 4Clinical Neurosciences, Imperial College Healthcare NHS Trust, London, UK; 5National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK

Abstract: Stroke is a leading cause of death and disability worldwide. Stem cell therapy is an emerging therapeutic modality with evidence of significant benefits in preclinical stroke models. A number of phase I and II clinical trials have now been completed, with several more currently under way. Translation to the bedside, however, remains a long way off, and there are many questions that remain unanswered. This review will summarize the current evidence and ongoing clinical trials worldwide, and explore the challenges to making this a realistic treatment option for the future.

Keywords: stroke, stem cells, clinical trials

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.